UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or Section 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification Number) |
(
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading |
Name of each exchange | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 2.02. Results of Operations and Financial Condition
On August 25, 2023, Abacus Life, Inc. released the historical second quarter 2022 financials for Abacus Settlements, LLC and Longevity Market Assets, LLC (the predecessor companies which merged with and into the Company effective as of June 30, 2023 and which currently comprise all of the business of the Company). The full text of this release is included here as Exhibit 99.1 hereto.
Item 9.01. Financial Statement and Exhibits.
(a) | Exhibits. |
99.1 | Historical Financial Release dated August 25, 2023 | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
* | Exhibit 99.1 is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall Exhibit 99.1 be deemed incorporated by reference into any filing of the Company under the Securities Act, in each case, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as expressly set forth in such filing. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
Abacus Life, Inc. | ||||||
Date: August 25, 2023 | By: | /s/ Jay Jackson | ||||
Name: | Jay Jackson | |||||
Title: | Chief Executive Officer |
2
Exhibit 99.1
ABACUS LIFE PRESENTS HISTORICAL QUARTERLY AND FULL YEAR 2022 FINANCIALS
ORLANDO, Fla. August 25, 2023 Abacus Life, Inc. (Abacus or the Company) (NASDAQ: ABL), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, today is releasing its unaudited historical quarterly and full year 2022 financials for Abacus Settlements, LLC (AS) and Longevity Market Assets, LLC (LMA and, together with AS, the Predecessor Companies). The Predecessor Companies are the predecessor companies which merged with and into the Company effective as of June 30, 2023 and which currently comprise all of the business of the Company. In addition, for illustrative purposes only, the Company is providing historical quarterly and full year 2022 financials of the Predecessor Companies on a pro forma combined basis (the Pro Forma Financials).
The Company is also providing financial information from last year to permit investors and analysts to understand more about the financial results for the business from 2022 for comparison purposes. The financial information related to Abacus Settlements, LLC and Longevity Market Assets, LLC is being presented for informational purposes only and should not be deemed to imply future performance of the Company. Anyone interested in the Companys current year financial information should consult its Quarterly Report on Form 10-Q.
Safe Harbor Statement
Statements made in this press release that are not historical facts, including statements accompanied by words such as will, believe, estimate, expect, intend, anticipate, goals, prospects, or similar words, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding the Companys plans and performance. These statements are based on managements estimates, assumptions and projections as of the date of this release and are not guarantees of future performance. Actual results may differ materially from the results expressed or implied in these statements as the result of risks, uncertainties and other factors including, but not limited to: the fact that our loss reserves are bases on estimates and may be inadequate to cover our actual losses; the failure to properly price our insurance policies; the geographic concentration of our business; the cyclical nature of our industry; the impact of regulation on our business; the effects of competition; failing to sustain our relationships with independent agencies; the failure to meet our investment objectives; the inability to acquire additional capital on favorable terms; the effects of acts of terrorism and the factors set forth in the Companys filings with the Securities and Exchange Commission (the SEC), including the Annual Report on Form 10-K and Quarterly Report on Form 10-Q and subsequent periodic reports. The Company cautions you not to place undue reliance on the forward-looking statements contained in this release. Any forwardlooking statements speak only as of their dates. The Company does not undertake any obligation to publicly update or revise any forward-looking statements to reflect future events, information or circumstances that arise after the date of this release.
Non-GAAP Financial Measures
This press release includes references to Adjusted EBITDA, a non-GAAP financial measure. Non-GAAP financial measures are financial measures that are derived from the consolidated financial statements, but that are not presented in accordance with generally accepted accounting principles in the United States (GAAP). The Company uses this non-GAAP financial measure and other key metrics internally to facilitate analysis of financial and business trends and for internal planning and forecasting purposes. The Company believes this non-GAAP financial measure, when taken collectively, may be helpful to investors because it provides consistency and comparability with past financial performance by excluding certain items that may not be indicative of the business, results of operations, or outlook. However, this non- GAAP financial measure has limitations as an analytical tool and is presented for supplemental informational purposes only. It should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. In particular, other companies, including companies in the Companys industry, may report Adjusted EBITDA or similarly titled measures but calculate them differently, which reduces its usefulness as comparative measures.
Reconciliation of GAAP Measures to Non-GAAP Measures
Set forth below Net Income in each of the following tables is a reconciliation of Adjusted EBITDA to GAAP Net Income, the most directly comparable GAAP measure, for each of the periods presented.
Basis of Pro Forma Presentation
The Pro Forma Financials have been adjusted to give pro forma effect to the combination of the Predecessor Companies with the Company. The adjustments in the Pro Forma Financials have been identified and presented to provide relevant information necessary for an accurate understanding of the Company following the mergers with the Predecessor Companies.
The Pro Forma Financials are provided for illustrative purposes only. The financial results may have been different had the Company and the Predecessor Companies always been combined. You should not rely on the Pro Forma Financials as being indicative of the historical results that would have been achieved had the Company and the Predecessor Companies always been combined or the future results that the Company will experience.
About Abacus
Abacus is a leading vertically integrated alternative asset manager specializing in life insurance products. Since 2004, the Company has purchased life insurance policies from consumers seeking liquidity and has actively managed those policies over time (via trading, holding, and/or servicing). With over $2.9 billion in face value of policies purchased, Abacus has helped thousands of clients maximize the value of their life insurance.
Over the past 19 years, the Company has built an institutionalized origination and portfolio management process that is supported by an 84-person team, long-term relationships with 78 institutional partners and 30,000 financial advisors, and the ability to operate in 49 states. The Company has serviced approximately $950 million in policies and has managed assets for large asset managers and third-party investment funds.
Abacus leadership team averages 20+ years of experience and consists of innovators since the life settlements industrys inception in the mid-90s.
The Company is a proud member of the Life Insurance Settlements Association (LISA) and complies with HIPAA and privacy laws to maintain and protect confidentiality of financial, health, and medical information. Abacus is also proud to be a BBB Accredited Business with an A+ rating.
www.Abacuslife.com
Contact:
Abacus Life Investor Relations
investors@abacuslife.com
Abacus Life Public Relations
press@abacuslife.com
LONGEVITY MARKET ASSETS, LLC AND ABACUS SETTLEMENTS, LLC COMBINED | ||||||||||||||||||||
PROFORMA STATEMENT OF OPERATIONS AND COMPREHENSIVE INCOME | ||||||||||||||||||||
FY 2022 | ||||||||||||||||||||
Three months ended March 31, |
Three months ended June 30, |
Three months ended September 30, |
Three months ended December 31, |
Full Year | ||||||||||||||||
2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2022 | ||||||||||||||||
Revenues |
||||||||||||||||||||
Origination Revenue |
7,322,747 | 5,691,916 | 6,031,481 | 6,157,319 | 25,203,463 | |||||||||||||||
Portfolio servicing revenue |
570,905 | 419,422 | 382,245 | 98,400 | 1,470,972 | |||||||||||||||
Active management revenue |
||||||||||||||||||||
Investment Income from life insurance policies held using investment method |
8,015,000 | 5,965,466 | 10,629,978 | 13,218,386 | 37,828,829 | |||||||||||||||
Change in fair value of life insurance policies (policies held using fair value method) |
1,291,492 | (1,291,492 | ) | 3,801,031 | 1,612,721 | 5,413,751 | ||||||||||||||
Total active management revenue |
9,306,492 | 4,673,974 | 14,431,008 | 14,831,106 | 43,242,581 | |||||||||||||||
Total revenues |
17,200,144 | 10,785,312 | 20,844,734 | 21,086,826 | 69,917,016 |
Cost of revenues (excluding depreciation stated below) |
6,635,650 | 4,238,051 | 5,618,972 | 6,313,464 | 22,806,136 | |||||||||||||||
Gross profit |
10,564,495 | 6,547,262 | 15,225,762 | 14,773,362 | 47,110,880 | |||||||||||||||
Operating expenses: |
||||||||||||||||||||
Sales and marketing |
630,000 | 1,019,498 | 14,905 | 931,737 | 2,596,140 | |||||||||||||||
General, administrative and other |
2,381,512 | 2,213,550 | 2,343,877 | 2,801,889 | 9,740,828 | |||||||||||||||
Other operating expense |
| | (2,141 | ) | | (2,141 | ) | |||||||||||||
Depreciation |
3,983 | 4,146 | 6,373 | 4,087 | 18,588 | |||||||||||||||
Change in fair value of debt |
41,634 | 333,879 | (1,235,032 | ) | 950,238 | 90,719 | ||||||||||||||
Unrealized (gain) loss on policies |
| (3,305,505 | ) | 3,305,505 | | | ||||||||||||||
Unrealized (gain) on investments |
15,953 | 1,039,022 | 246,846 | (256,199 | ) | 1,045,623 | ||||||||||||||
Total operating expenses |
3,073,082 | 1,304,590 | 4,680,334 | 4,431,751 | 13,489,758 | |||||||||||||||
Operating Income |
7,491,412 | 5,242,671 | 10,545,428 | 10,341,610 | 33,621,122 | |||||||||||||||
Other (expense) / income |
||||||||||||||||||||
Other (expense) |
(114,792 | ) | (127,181 | ) | 42,288 | (147,054 | ) | (346,740 | ) | |||||||||||
Interest (expense) |
0 | | (2,954 | ) | (48,661 | ) | (51,615 | ) | ||||||||||||
Interest income |
548 | 599 | 358 | 2,167 | 3,672 | |||||||||||||||
Total other (expense) / income |
(114,244 | ) | (126,582 | ) | 39,691 | (193,547 | ) | (394,682 | ) |
Net income before tax |
7,377,169 | 5,116,089 | 10,585,120 | 10,148,063 | 33,226,440 | |||||||||||||||
Income tax (benefit) |
1,325 | 296,806 | 242,544 | 351,286 | 891,961 | |||||||||||||||
Net income |
7,375,844 | 4,819,283 | 10,342,576 | 9,796,777 | 32,334,479 | |||||||||||||||
Less: Net income (loss) attributable to non-controlling interests |
| 406,641 | 405,967 | (27,844 | ) | 784,764 | ||||||||||||||
Net income attributable to Longevity Market Assets, LLC |
7,375,844 | 4,502,884 | 9,936,609 | 9,824,621 | 31,549,715 | |||||||||||||||
Net income |
7,375,844 | 4,819,283 | 10,342,576 | 9,796,777 | 32,334,479 | |||||||||||||||
Depreciation and amortization expense |
3,983 | 4,146 | 6,373 | 4,087 | 18,588 | |||||||||||||||
Income tax |
1,325 | 296,806 | 242,544 | 351,286 | 891,961 | |||||||||||||||
Other (expense) |
114,792 | 127,181 | (42,288 | ) | 147,054 | 346,740 | ||||||||||||||
Interest expense |
(0 | ) | | 2,954 | 48,661 | 51,615 | ||||||||||||||
Interest income |
(548 | ) | (599 | ) | (358 | ) | (2,167 | ) | (3,672 | ) | ||||||||||
Loss on change in fair value of debt |
41,634 | 333,879 | (1,235,032 | ) | 950,238 | 90,719 | ||||||||||||||
Unrealized (gain) on investments |
15,953 | 1,039,022 | 246,846 | (256,199 | ) | 1,045,623 | ||||||||||||||
Adjusted EBITDA |
7,552,983 | 6,619,719 | 9,563,615 | 11,039,736 | 34,776,053 |
LONGEVITY MARKET ASSETS, LLC
STATEMENT OF OPERATIONS AND COMPREHENSIVE INCOME
FY 2022
Three months ended March 31, |
Three months ended June 30, |
Three months ended September 30, |
Three months ended December 31, |
Full Year | ||||||||||||||||
2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2022 | ||||||||||||||||
Revenues |
||||||||||||||||||||
Portfolio servicing revenue |
||||||||||||||||||||
Related-party service revenue |
200,905 | 419,253 | 132,220 | 65,921 | 818,299 | |||||||||||||||
Portfolio Servicing revenue |
370,000 | 169 | 250,025 | 32,479 | 652,673 | |||||||||||||||
Total portfolio servicing revenue |
570,905 | 419,422 | 382,245 | 98,400 | 1,470,972 | |||||||||||||||
Active management revenue |
||||||||||||||||||||
Investment Income from life insurance policies held using investment method |
8,015,000 | 5,965,466 | 10,629,978 | 13,218,386 | 37,828,829 | |||||||||||||||
Change in fair value of life insurance policies (policies held using fair value method) |
1,291,492 | (1,291,492 | ) | 3,801,031 | 1,612,721 | 5,413,751 |
Total active management revenue |
9,306,492 | 4,673,974 | 14,431,008 | 14,831,106 | 43,242,581 | |||||||||||||||
Total revenues |
9,877,397 | 5,093,396 | 14,813,253 | 14,929,506 | 44,713,553 | |||||||||||||||
Cost of revenues (excluding depreciation stated below) |
1,419,956 | 666,119 | 1,754,894 | 2,404,163 | 6,245,131 | |||||||||||||||
Gross profit |
8,457,441 | 4,427,277 | 13,058,360 | 12,525,344 | 38,468,422 | |||||||||||||||
Operating expenses: |
||||||||||||||||||||
Sales and marketing |
630,000 | 1,019,498 | 14,905 | 931,737 | 2,596,140 | |||||||||||||||
General, administrative and other |
641,205 | 5,499 | 59,816 | 359,883 | 1,066,403 | |||||||||||||||
Other operating expense |
| | (2,141 | ) | | (2,141 | ) | |||||||||||||
Depreciation |
1,043 | 1,098 | 3,212 | 1,071 | 6,423 | |||||||||||||||
Change in fair value of debt |
41,634 | 333,879 | (1,235,032 | ) | 950,238 | 90,719 | ||||||||||||||
Unrealized (gain) loss on policies |
| (3,305,505 | ) | 3,305,505 | | | ||||||||||||||
Unrealized (gain) on investments |
15,953 | 1,039,022 | 246,846 | (256,199 | ) | 1,045,623 | ||||||||||||||
Total operating expenses |
1,329,835 | (906,509 | ) | 2,393,111 | 1,986,729 | 4,803,168 | ||||||||||||||
Operating Income |
7,127,605 | 5,333,786 | 10,665,248 | 10,538,614 | 33,665,254 | |||||||||||||||
Other (expense) / income |
||||||||||||||||||||
Other (expense) |
(114,792 | ) | (127,455 | ) | 42,288 | (147,054 | ) | (347,013 | ) |
Interest (expense) |
| | | (42,798 | ) | (42,798 | ) | |||||||||||||
Interest income |
| | | 1,474 | 1,474 | |||||||||||||||
Total other (expense) / income |
(114,792 | ) | (127,455 | ) | 42,288 | (188,378 | ) | (388,337 | ) | |||||||||||
Net income before tax |
7,012,813 | 5,206,331 | 10,707,536 | 10,350,236 | 33,276,917 | |||||||||||||||
Income tax (benefit) |
| 296,806 | 241,962 | 351,176 | 889,943 | |||||||||||||||
Net income |
7,012,813 | 4,909,525 | 10,465,574 | 9,999,061 | 32,386,974 | |||||||||||||||
Less: Net income (loss) attributable to non-controlling interests |
| 406,641 | 405,967 | (27,844 | ) | 784,764 | ||||||||||||||
Net income attributable to Longevity Market Assets, LLC |
7,012,813 | 4,502,884 | 10,059,607 | 10,026,905 | 31,602,210 | |||||||||||||||
Net income |
7,012,813 | 4,909,525 | 10,465,574 | 9,999,061 | 32,386,973 | |||||||||||||||
Depreciation and amortization expense |
1,043 | 1,098 | 3,212 | 1,071 | 6,423 | |||||||||||||||
Income tax |
| 296,806 | 241,962 | 351,176 | 889,943 | |||||||||||||||
Other (expense) |
114,792 | 127,455 | (42,288 | ) | 147,054 | 347,013 | ||||||||||||||
Interest expense |
| | | 42,798 | 42,798 | |||||||||||||||
Interest income |
| | | (1,474 | ) | (1,474 | ) | |||||||||||||
Loss on change in fair value of debt |
41,634 | 333,879 | (1,235,032 | ) | 950,238 | 90,719 | ||||||||||||||
Unrealized (gain) on investments |
15,953 | 1,039,022 | 246,846 | (256,199 | ) | 1,045,623 | ||||||||||||||
Adjusted EBITDA |
7,186,236 | 6,707,785 | 9,680,275 | 11,233,724 | 34,808,019 |
ABACUS SETTLEMENTS, LLC
STATEMENT OF OPERATIONS
FY 2022
Three months ended March 31, |
Three months ended June 30, |
Three months ended September 30, |
Three months ended December 31, |
Full Year | ||||||||||||||||
2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2022 | ||||||||||||||||
Revenue |
2,441,680 | 743,388 | 1,766,853 | 2,098,086 | 7,050,007 | |||||||||||||||
Related party revenue |
4,881,067 | 4,948,528 | 4,264,628 | 4,059,233 | 18,153,456 | |||||||||||||||
Total revenue |
7,322,747 | 5,691,916 | 6,031,481 | 6,157,319 | 25,203,463 | |||||||||||||||
Cost of sales |
||||||||||||||||||||
Cost of sales (exclusive of items shown separately below) |
2,308,688 | 956,625 | 933,089 | 1,340,069 | 5,538,470 | |||||||||||||||
Related party cost of sales |
2,907,005 | 2,615,307 | 2,930,990 | 2,569,233 | 11,022,535 | |||||||||||||||
Total cost of sales |
5,215,693 | 3,571,932 | 3,864,079 | 3,909,302 | 16,561,005 | |||||||||||||||
Gross profit |
2,107,054 | 2,119,984 | 2,167,402 | 2,248,018 | 8,642,458 | |||||||||||||||
Operating expenses: |
||||||||||||||||||||
General and administrative expenses |
1,740,307 | 2,208,051 | 2,284,061 | 2,442,006 | 8,674,425 |
Depreciation and amortization expense |
2,940 | 3,048 | 3,161 | 3,016 | 12,165 | |||||||||||||||
Total operating expenses |
1,743,247 | 2,211,099 | 2,287,222 | 2,445,022 | 8,686,590 | |||||||||||||||
Income (loss) from operations |
363,807 | (91,115 | ) | (119,820 | ) | (197,004 | ) | (44,132 | ) | |||||||||||
Other income (expense) |
||||||||||||||||||||
Interest income |
548 | 599 | 358 | 694 | 2,199 | |||||||||||||||
Interest expense |
0 | | (2,954 | ) | (5,863 | ) | (8,817 | ) | ||||||||||||
Other income (expense) |
| 273 | | | 273 | |||||||||||||||
Total other income (expense) |
548 | 872 | (2,596 | ) | (5,169 | ) | (6,345 | ) | ||||||||||||
Income before income taxes |
364,356 | (90,242 | ) | (122,417 | ) | (202,173 | ) | (50,477 | ) |
Provision for income taxes |
1,325 | | 582 | 111 | 2,018 | |||||||||||||||
Net income and comprehensive income (loss) |
$ | 363,031 | $ | (90,242 | ) | $ | (122,999 | ) | $ | (202,284 | ) | $ | (52,494 | ) | ||||||
Net income and comprehensive income (loss) |
$ | 363,031 | $ | (90,242 | ) | $ | (122,999 | ) | $ | (202,284 | ) | (52,494 | ) | |||||||
Depreciation and amortization expense |
2,940 | 3,048 | 3,161 | 3,016 | 12,165 | |||||||||||||||
Provision for income taxes |
1,325 | | 582 | 111 | 2,018 | |||||||||||||||
Interest income |
(548 | ) | (599 | ) | (358 | ) | (694 | ) | (2,199 | ) | ||||||||||
Interest expense |
0 | | (2,954 | ) | (5,863 | ) | (8,817 | ) | ||||||||||||
Adjusted EBITDA |
$ | 366,747 | $ | (87,793 | ) | $ | (122,567 | ) | $ | (205,714 | ) | $ | (49,327 | ) |